Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Pemetrexed, sold under the brand name Alimta among others, is a chemotherapy medication for the treatment of pleural mesothelioma and non-small cell lung cancer (NSCLC).
The analysis highlights Applications, Medical use and Mechanism of action as prominent areas in the source structure around Pemetrexed.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Pemetrexed shows recurring relationship patterns in the source. For example, Pemetrexed → ABC, As, B12, It, MDR1, MRP-5, Orai3, The Another extracted example is Pemetrexed → By, DHFR, DNA, GARFT, It, RNA, TS. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
cancer cisplatin mesothelioma treatment lung medication drug acid carboplatin patients non-small cell nsclc use brand administration normal name alimta others
TTTA extracted 60 structured relationships around Pemetrexed. Examples in this analysis include Pemetrexed → 3D model (JSmol) → Interactive image and Pemetrexed → AHFS/Drugs.com → Monograph. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Pemetrexed | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Pemetrexed | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Pemetrexed | ATC code | L01BA04 (WHO) | 1.00 | infobox |
| Pemetrexed | Bioavailability | NA | 1.00 | infobox |
| Pemetrexed | CAS Number | 137281-23-3 N | 1.00 | infobox |
| Pemetrexed | ChEMBL | ChEMBL225072 Y | 1.00 | infobox |
| Pemetrexed | ChemSpider | 393879 Y | 1.00 | infobox |
| Pemetrexed | CompTox Dashboard (EPA) | DTXSID2048329 | 1.00 | infobox |
| Pemetrexed | DrugBank | DB00642 Y | 1.00 | infobox |
| Pemetrexed | ECHA InfoCard | 100.205.735 | 1.00 | infobox |
| Pemetrexed | Elimination half-life | 3.5 hours | 1.00 | infobox |
| Pemetrexed | Excretion | Kidney | 1.00 | infobox |
| Pemetrexed | Formula | C20H21N5O6 | 1.00 | infobox |
| Pemetrexed | KEGG | D07472 Y | 1.00 | infobox |
| Pemetrexed | KEGG | as salt: D06503 Y | 1.00 | infobox |
| Pemetrexed | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Pemetrexed | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Pemetrexed | Legal status | US: ℞-only | 1.00 | infobox |
| Pemetrexed | Legal status | EU: Rx-only | 1.00 | infobox |
| Pemetrexed | License data | US DailyMed: Pemetrexed | 1.00 | infobox |
| Pemetrexed | Metabolism | Negligible | 1.00 | infobox |
| Pemetrexed | Molar mass | 427.417 g·mol−1 | 1.00 | infobox |
| Pemetrexed | Pregnancy category | AU: D | 1.00 | infobox |
| Pemetrexed | Protein binding | 81% | 1.00 | infobox |
| Pemetrexed | PubChem CID | 135410875 | 1.00 | infobox |
| Pemetrexed | Routes of administration | Intravenous | 1.00 | infobox |
| Pemetrexed | Trade names | Alimta, Pemfexy, Ciambra, others | 1.00 | infobox |
| Pemetrexed | UNII | 04Q9AIZ7NO | 1.00 | infobox |
The concept neighborhoods around Pemetrexed bring nearby vocabulary together. In this analysis, examples include Cancer, Mesothelioma and Acid. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Pemetrexed, one of the stronger structural bridges in this analysis connects Pemetrexed with Medical use. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Pemetrexed to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as Applications, Medical use & Mechanism of action, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Pemetrexed · EN edition · Analysis: TopicsToTalkAbout